100% found this document useful (1 vote)
318 views33 pages

Chemotherapy - Alkylating Agents

Download as pdf or txt
Download as pdf or txt
Download as pdf or txt
You are on page 1/ 33

Chemotherapy Rotations:

Alkylating Agents and Platinum


Compounds
Nicole Shilkofski, M.D.

Learning Objectives
Explain mechanisms of alkylating agents,
discriminating key differences between bifunctional
and monofunctional agents in creating inter-strand
cross-links in cancer cell DNA.
Understand the likely mechanisms of action of
platinum compounds and the association of antineoplastic platinum compounds and kidney damage.
Gain familiarity with common side effects associated
with anti-neoplastic drug administration, including
neutropenia, anemia, thrombocytopenia, hair loss, and
gonadal dysfunction

Alkylating Antineoplastic Agents


Chemical assault on DNA of cancer cells
Modify functional groups on genomic DNA
and protein of cells (attaches alkyl group to
DNA- usually guanine base of DNA, most
commonly number 7 nitrogen atom of
purine ring)
Explains both ability to kill cancer cells via
DNA damage but also cytotoxic effects on
cells that divide frequently (GIT, bone
marrow, testicles, ovaries)

History of Chemical Warfare:


Exposure to Alkylating Agents in Wartime:
World War II- December 1943

Sulfur mustard gas is generated when sulfur


chloride is added to ethylene
An estimated 9,000,000 shells filled with sulfur
mustard were fired in World War I with some
1,205,655 nonfatal casualties and 91,198 deathsskin burns, alkylation of nerve endings in
diaphragm= major cause of death

Side effects post gas experienced similar to


antineoplastic agents (hair loss, alterations in
blood counts etc.)

WWII: Bombing in ItalyUS Liberty ship, which


had been carrying a
secret cargo of 2,000
M47A1 World War I
type mustard gas bombs,
each of which held 60-70
lbs of sulfur mustard

Within a day, symptoms of mustard poisoning began appearing


in rescued casualties, in medical personnel, and in local residents
(among military personnel, 628 became blind and developed
chemical burns; 83 ultimately died); medical personnel described a
garlic-like odor
A young medical officer described the striking reduction in
white blood cell counts, particularly in lymphocyte counts,
in addition to the expected chemical burns

Reactive Nucleophiles in DNA

Drugs are electophiles- modify nucleophiles in DNA: N7


position of Guanine is most commonly modified

Bifunctional vs monofunctional
Alkylating Agents
Bifunctional (dialkylating)- can react with
2 different residues resulting in cross
linkage (antineoplastic drugs)
Monofunctional (monoalkylating)- can
react with only one N7 of guanine so do not
prevent separation of DNA strands of helix
but prevent DNA processing enzymes from
accessing DNA (mutagens and carcinogens)

Chemistry of Bifunctional Alkylating Agent Damage


Cl
CH2
R

immonium ion
CH2

CH2

N:

R
CH2

CH2

alkylating agent

CH2

CH2

CH2

Cl

Cl

+
N

CH2
CH

N
guanine (or other
intracellular nucleophile)

CH2

N
CH2

carbonium ion

CH2
Cl

Chemistry of Bifunctional Alkylating Agent Damage


(continued)
N

CH2

N:

CH2
R

CH2

CH

CH2
Cl

adducted guanine

guanine

+
CH2
guanine

CH2

CH2

CH2

CH2
guanine

CH2 CH2 N

R
immonium ion

CH2

carbonium ion

Interstrand DNA Cross-link Caused by


Bifunctional Alkylating Agent

Stop tumor growth by crosslinking guanine nucleobases in DNA


double helix strands so strands cannot uncoil and separate and
cells can no longer divide

DNA Cross-links Interfere with Replication

bifunctional
alkylating agent
cross-link

DNA replication

R
N

bifunctional
alkylating agent
cross-link

Nitrogen Mustards in Clinical Use

CH2

CH2

Cl

CH2

CH2

Cl

CH3
mechlorethamine
(nitrogen mustard)
HOOC

CH2 CH2 CH2

HOOC CH CH2

chlorambucil

NH2
melphalan (L-phenylalanine
mustard; (L-PAM)

N
O

NH
O

P
O

cyclophosphamide

P
O

CH2
NH

CH2
CH2

ifosfamide

Cl
CH2

Cl

Pharmacology of the Nitrogen Mustards

Drug

Principal Route
of Administration

mechlorethamine
chlorambucil
melphalan

cyclophosphamide
ifosfamide

Plasma t1/2 Characteristics

intravenous

very short
(1 minute)

oral
oral

1.5 hours
1.5 hours

oral/intravenous
intravenous

7 hours
7 hours

rapid action
potent vessicant
slow rate of
conversion to
carbonium ion

***must be
activated by
liver metabolism
(prodrugs)

Toxicities of the Nitrogen Mustards


Drug

Acute

Delayed (Dose-Limiting)

mechlorethamine severe nausea/vomiting, bone marrow suppression,


phlebitis/skin irritation
amenorrhea
chlorambucil

nausea/vomiting

bone marrow suppression

melphalan

mild nausea

bone marrow suppression

cyclophosphamide

nausea/vomiting

bone marrow suppression,


hemorrhagic cystitis,
alopecia, amenorrhea,
sterility, water retention

ifosfamide

nausea/vomiting

bone marrow suppression,


hemorrhagic cystitis,
alopecia, neurotoxicity,
water retention

Platinum based chemotherapy


drugs
Often called Alkylating like drugs
Do not have an alkyl group but still damage
DNA by interfering with DNA repair
Also bind at N7 of guanine

Platinum Compounds: Cisplatin


Cross-Links to DNA and Protein

Platinum Compounds in Clinical Use


O
NH2

NH2

Pt

Pt
Cl

NH2

O
O

Cl

O
carboplatin

cisplatin
O

NH2

O
Pt
O
O

NH2
oxaliplatin

NH2

Pharmacology of the Platinum Compounds


Drug

cisplatin

Principal Route
of Administration
intravenous
intraperitoneal

Plasma t1/2

20-40 minutes

Characteristics

Rapid reaction; 30-50%


of drug excreted in urine
within 24 hours (therefore
has side effect of kidney
damage)

carboplatin

oxaliplatin

intravenous

intravenous

2-3 hours

Slow reaction

2-3 hours

Slow reaction

Toxicities of the Platinum Compounds


Drug

cisplatin

carboplatin

oxaliplatin

Acute

severe nausea/vomiting,
anaphylactic reactions

moderate nausea/
vomiting

nausea/vomiting

Delayed (Dose-Limiting)

***nephrotoxicity, ototoxicity,
peripheral neuropathy,
bone marrow suppression

bone marrow suppression

bone marrow suppression,


neurotoxicity, diarrhea

Chemotherapy-Induced Nausea and Vomiting


cerebral cortex

metabolic disorders:
Uremia, ketoacidosis,
hypoxia

chemoreceptor
trigger zone
(area postrema)

anticipitory emesis:
elicited by chemotherapy
(before administration)

vomiting center

motion sickness
inner ear disorders

(neural networks in the


nucleus tractus solitarius)

drugs: opiates, anesthetic


agents, cardiac glycosides,
chemotherapy (immediate)

peripheral receptors
(vagal and splanchnic nerves)

vestibular
center
intestinal injury
toxins
chemotherapy (late)
radiation therapy

Treatment and Prophylaxis of ChemotherapyInduced Nausea and Vomiting


anti-emetic

selective serotonin type 3


(5-HT3) receptor antagonists
ondansetron, granisetron
dolasetron
benzamides
metoclopramide
corticosteroids
dexamethasone, methylprednisolone
phenothiazines
prochlorperazine
promethazine, thiethylperazine
benzodiazepines
lorazepam
butyrophenones
haloperidol, droperidol
cannabinoids
dronabinol, nabilone

mechanism of action

5-HT3 receptor
blockade

dopamine and 5-HT3


receptor blockade
unknown
dopamine receptor
blockade
anxiolytic, amnesic
dopamine receptor
blockade
general psychotropic

Other Toxicities: Effects on Rapidly Replicating Cell Populations

hematopoietic stem cells are resistant to cyclophosphamide

Timing of Chemotherapy-Induced Neutropenia


Dose affects severity but not timing of decrease in ANC

Treatment of Chemotherapy-Induced
Bone Marrow Dysfunction
Transfusion of blood components
red blood cells
platelets
granulocytes (rare- cells dont live long)

Hematopoietic cytokines
erythropoietin
G-CSF (filgrastim)
GM-CSF (sargramostim)

Effect of G-CSF Treatment on ChemotherapyInduced Neutropenia


daily G-CSF

chemotherapy

Chemotherapy Effects on Gonadal Function


Age/Gender
pubertal (non-proliferating) gonads remarkably resistant
to cytotoxic effects of anti-neoplastic drugs

breast cancer treatment: AC (doxorubicin/cyclophosphamide)


amenorrhea 96% women age 40-49 versus 0% women age <30)
male gonads more sensitive than female gonads

Chemotherapy agent(s) and dose, other cancer therapy


alkylating agents/platinum compounds particularly bad
Hodgkins disease treatment: MOPP (alkylating agents) with
97% azoospermia (13% recovery)
70% versus 10% recovery of spermatogenesis in boys
after treatment with cyclophosphamide at lower vs higher doses

exogenous
chemotherapy
carcinogens
other toxins/irritants

endogenous
metabolism
inflammation
cell signaling
many enzymes

cytochrome P450's

oxidants
electrophiles

inactivated
detoxification
(GSTP1, GSTs, GPx, etc.)

cell death
repair

proliferation

transformation
mutation

genome
damage

Chemotherapy-Associated Acute Myeloid Leukemia


(AML) After Treatment for Hodgkins Disease*
n = 1329 Hodgkins disease survivors
treatment
actuarial risk of AML
________________________________
RT alone

0%

chemotherapy alone

1.4% +/- 2.3%

RT + MOPP (alkylators)

10.2% +/- 5.2%

RT + other alkylators

4.8% +/- 1.6%

*Valagussa et al. J Clin Oncol 4: 830 (1986)

Important Take Home Points


Bifunctional vs monofunctional alkylating
agents
Pharmacologic mechanism of action of
alkylators on DNA
Side effects of alkylating and platinum
agents
Chemotherapy induced nausea mechanisms
Effects of antineoplastic drugs on gonad
function

You might also like